| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2010693 | Pharmacological Reports | 2016 | 5 Pages |
Abstract
Coenzyme Q10 is the only endogenously synthesized lipid with a redox function which exhibits broad tissue and intracellular distribution in mammals. Beneficial effects of CoenzymeQ10 supplementation were observed in several age-related diseases including heart failure. CoQ10 (coenzyme Q10) level is significantly decreased in patients with this disease, which correlates with severity of clinical symptoms. Supplementation with various pharmaceutical formulations of CoQ10 improves impaired cardiac function and clinical course of heart failure. Current data from clinical trials indicate that CoQ10 can significantly reduce morbidity and mortality of heart failure patients in addition to guideline recommended pharmacotherapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Jerzy Jankowski, Katarzyna Korzeniowska, Artur Cieślewicz, Anna Jabłecka,